Science Ayrmid Unveils Promising Results for Motixafortide in Gene Therapy Ayrmid has reported new findings demonstrating the efficacy of Motixafortide in mobilizing hematopoietic stem cells (HSCs) for patients suffering from sickle cell disease and... Editorial4 February, 2026